Search research articles
Contact Us
Filters
Showing results (661-670 of 710) with videos related to
Page
of 71
Sort By:
The Lancet. Oncology
|
December 28, 2020
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial
Robert D Morgan, Iain A McNeish, Adrian D Cook, et al.
Journal of Gynecologic Oncology
|
January 23, 2015
Asian Society of Gynecologic Oncology International Workshop 2014
Jeong Yeol Park, Hextan Yuen Sheung Ngan, Won Park, et al.
JACC. Cardiovascular Interventions
|
October 9, 2020
Effect of Ticagrelor on Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction (HEALING-AMI)
Yongwhi Park, Jin Sin Koh, Jae-Hwan Lee, et al.
The New England Journal of Medicine
|
December 7, 2021
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer
Philipp Harter, Jalid Sehouli, Ignace Vergote, et al.
Journal of Gynecologic Oncology
|
October 6, 2010
Asian society of gynecologic oncology workshop 2010
Dong Hoon Suh, Jae Weon Kim, Mohamad Farid Aziz, et al.
JACC. Cardiovascular Interventions
|
February 10, 2024
Prognostic Implications of Quantitative Flow Ratio and Plaque Characteristics in Intravascular Ultrasound-Guided Treatment Strategy
You-Jeong Ki, Jeehoon Kang, Jinlong Zhang, et al.
Journal of Gynecologic Oncology
|
October 25, 2024
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial
Janice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson, et al.
Clinical Therapeutics
|
February 7, 2018
A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial
Soon Jun Hong, Han Saem Jeong, Jeong Cheon Ahn, et al.
The New England Journal of Medicine
|
November 14, 2019
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
Robert L Coleman, Nick M Spirtos, Danielle Enserro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2023
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study
Yvette Drew, Jae-Weon Kim, Richard T Penson, et al.
Page
of 71
Search research articles
Search
Showing results (661-670 of 710) with videos related to
Sort By:
Page
of 71
The Lancet. Oncology
|
December 28, 2020
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial
Robert D Morgan, Iain A McNeish, Adrian D Cook, et al.
Journal of Gynecologic Oncology
|
January 23, 2015
Asian Society of Gynecologic Oncology International Workshop 2014
Jeong Yeol Park, Hextan Yuen Sheung Ngan, Won Park, et al.
JACC. Cardiovascular Interventions
|
October 9, 2020
Effect of Ticagrelor on Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction (HEALING-AMI)
Yongwhi Park, Jin Sin Koh, Jae-Hwan Lee, et al.
The New England Journal of Medicine
|
December 7, 2021
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer
Philipp Harter, Jalid Sehouli, Ignace Vergote, et al.
Journal of Gynecologic Oncology
|
October 6, 2010
Asian society of gynecologic oncology workshop 2010
Dong Hoon Suh, Jae Weon Kim, Mohamad Farid Aziz, et al.
JACC. Cardiovascular Interventions
|
February 10, 2024
Prognostic Implications of Quantitative Flow Ratio and Plaque Characteristics in Intravascular Ultrasound-Guided Treatment Strategy
You-Jeong Ki, Jeehoon Kang, Jinlong Zhang, et al.
Journal of Gynecologic Oncology
|
October 25, 2024
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial
Janice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson, et al.
Clinical Therapeutics
|
February 7, 2018
A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial
Soon Jun Hong, Han Saem Jeong, Jeong Cheon Ahn, et al.
The New England Journal of Medicine
|
November 14, 2019
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
Robert L Coleman, Nick M Spirtos, Danielle Enserro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2023
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study
Yvette Drew, Jae-Weon Kim, Richard T Penson, et al.
Page
of 71